How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Microsoft Corp. | €417.40 | €501.09 |
| Amazon.com Inc. | €225.35 | €258.70 |
| Applied Materials Inc. | €461.85 | €496.17 |
| Security | Price | Target price |
|---|---|---|
| Clorox Co. | €91.62 | €91.19 |
| Western Union Co. | €6.29 | €7.01 |
| Socket Mobile Inc. | ? | - |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B Western Digital Corp. | RudolfL | 18.77% |
| B Micron Technology Inc. | UBS Group AG | 16.53% |
| B Ceva Inc. | TD Cowen | 10.53% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S Socket Mobile Inc. | Bankster | -55.00% |
| S Socket Mobile Inc. | michaelkr | -28.95% |
| S Capricor Therapeutics Inc | Bankster | -22.55% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
Space X
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
China Sxt Pharmaceuticals Inc.
WKN: A411L7 / Name: China Sxt Pharmaceuticals Inc. / Stock / ? /
Pros
Cons
EyePoint Pharmaceuticals Inc.
WKN: A2QJRU / Symbol: EYPT / Name: EyePoint Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Sandisk Corp. | €1,560.0 | 9.090% |
| Marvell Technology Inc. | €206.65 | 7.740% |
| Western Digital Corp. | €472.30 | 7.110% |
| Lumentum Holdings Inc | €853.70 | 6.670% |
| Micron Technology Inc. | €892.00 | 6.050% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Constellation Brands Inc. | €113.50 | -5.810% |
| Super Micro Computer Inc. | €33.04 | -4.070% |
| ServiceNow Inc. | €103.00 | -3.920% |
| Whirlpool Corp. | €34.36 | -3.890% |
| Centene Corp. | €56.06 | -3.880% |
Courses
sharewise Introduction
sharewise advanced features
Also you get more information about our Pro and Cons feature, where we bring the wisdom of crowds to a new level.
For discussing with your friends and managing your investment clubs we will show you how to create your own stock debates.#
Predictions
Marvell Technology Inc.
16:45
17.08.27
17:03
Top News
Syntec Optics Q2 Earnings Call Highlights
Key Points
- Interested in Syntec Optics Holdings, Inc.? Here are five stocks we like better.
- Record Q2 performance: Revenue rose 26% year over year to approximately $8.3 million, while gross
Freightos Q2 Earnings Call Highlights
Key Points
- Interested in Freightos Limited? Here are five stocks we like better.
- Q2 performance exceeded expectations: Revenue rose 3% year over year to $7.7 million, while the adjusted EBITDA
argenx VYVGART Hits Phase III Goal in Autoimmune Myositis, Eyes IMNM Filing
Key Points
- Interested in argenex SE? Here are five stocks we like better.
- VYVGART Hytrulo met the Phase III primary endpoint in the combined immune-mediated necrotizing myopathy (IMNM) and
PagSeguro Digital Q2 Earnings Call Highlights
Key Points
- Interested in PagSeguro Digital Ltd.? Here are five stocks we like better.
- PagSeguro maintained its full-year targets despite Brazil’s challenging macroeconomic environment. Q2
Cosan Q2 Earnings Call Highlights
Key Points
- Interested in Cosan S.A. Sponsored ADR? Here are five stocks we like better.
- Debt reduction accelerated: Cosan’s expanded net debt fell 20% sequentially to BRL 9.2 billion, supported
OTLK Q3 Earnings Call Maps LYTENAVA U.S. Launch and Sales Ramp
Outlook Therapeutics, Inc. OTLK used its fiscal third-quarter 2026 call to shift attention from approval to commercialization, detailing LYTENAVA's U.S. launch plan after FDA approval for wet AMD.
Best Momentum Stock to Buy for August 17th
Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, August 17th:
PhenixFIN PFX: This internally managed, closed-end, business development company
4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma
Artificial intelligence (AI) is poised to reshape pharmaceutical research by addressing some of the industry's most persistent challenges: lengthy timelines, high development costs and substantial
How Much Upside is Left in China Yuchai (CYD)? Wall Street Analysts Think 51.79%
China Yuchai (CYD) closed the last trading session at $45.24, gaining 3.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts Predict a 32.15% Upside in Broadcom Inc. (AVGO): Here's What You Should Know
Broadcom Inc. (AVGO) closed the last trading session at $392.99, gaining 6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
DeFi Development Q2 Earnings Call Highlights
Key Points
- Interested in DeFi Development Corp.? Here are five stocks we like better.
- DeFi Development is targeting long-term SOL-per-share growth through validator operations, staking
News
Wall Street Analysts Believe Celestica (CLS) Could Rally 38.34%: Here's is How to Trade
Shares of Celestica (CLS) have gained 11.2% over the past four weeks to close the last trading session at $335.05, but there could still be a solid upside left in the stock if short-term price
How Much Upside is Left in Custom Truck One Source (CTOS)? Wall Street Analysts Think 25.07%
Shares of Custom Truck One Source, Inc. (CTOS) have gained 1.8% over the past four weeks to close the last trading session at $10.53, but there could still be a solid upside left in the stock if
Wall Street Analysts See a 65.78% Upside in Aevex (AVEX): Can the Stock Really Move This High?
Shares of Aevex (AVEX) have gained 48.6% over the past four weeks to close the last trading session at $21.54, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts See an 182.18% Upside in Q32 Bio (QTTB): Can the Stock Really Move This High?
Shares of Q32 Bio (QTTB) have gained 0.7% over the past four weeks to close the last trading session at $15.15, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts Think EnerSys (ENS) Could Surge 25.07%: Read This Before Placing a Bet
EnerSys (ENS) closed the last trading session at $203.4, gaining 3.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Believe Cogent (CCOI) Could Rally 65.08%: Here's is How to Trade
Shares of Cogent Communications (CCOI) have gained 3.1% over the past four weeks to close the last trading session at $11.31, but there could still be a solid upside left in the stock if short-term
Does Cerebras (CBRS) Have the Potential to Rally 29.44% as Wall Street Analysts Expect?
Cerebras (CBRS) closed the last trading session at $218.98, gaining 26.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
How Much Upside is Left in Grand Canyon Education (LOPE)? Wall Street Analysts Think 35.23%
Grand Canyon Education (LOPE) closed the last trading session at $144.2, gaining 2.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set
After Golden Cross, BlackRock (BLK)'s Technical Outlook is Bright
BlackRock (BLK) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, BLK's 50-day simple moving average broke out above its 200-day
Contest
Still running
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.